Doceree, which operates a network of physician-only platforms for programmatic messaging, on Wednesday said it has raised $35 million in a Series B funding round led by Creaegis,
Existing investors Eight Roads Ventures and F-Prime Capital also participated in the round, as per a statement. The funds will enable Doceree to accelerate product development, augment technologies, scale global expansion and expand the team, it added.
Founded in 2019, Doceree helps pharmaceutical and life-sciences companies and healthcare media agencies with solutions that seamlessly reach healthcare professionals on their networks and within their digital workflows, to achieve better patient health outcomes.
The New Jersey-headquartered startup had last raised capital in April 2022 with a $11 million in Series A funding round led by Eight Roads Ventures, a global investment firm backed by Fidelity. The next month, Eight Roads had announced launching its first dedicated India healthcare and life sciences fund of $250 million.
“The pharma messaging space is evolving at a fast pace and our solutions are aligned to meet the immediate requirements of the life sciences industry. The investment speaks volumes about the value we are creating in the space,” Harshit Jain, founder and global CEO, Doceree, said.